IP Verse

Medecins Du Monde Et Al competitive analysis

Loading summary...

Latest oppositions filed by Medecins Du Monde Et Al

Explore patent oppositions filed by Medecins Du Monde Et Al against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3214091
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019

Latest publications and patents of Medecins Du Monde Et Al New

Explore the latest publications and patents granted to Medecins Du Monde Et Al, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Medecins Du Monde Et Al

Discover the latest PTAB cases involving Medecins Du Monde Et Al, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Medecins Du Monde Et Al with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDECINS DU MONDE ET AL1 - - -
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - 38 - 7